ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=Interleukin-27 subunit alpha; Short=IL-27 subunit alpha; Short=IL-27-A; Short=IL27-A;AltName: Full=p28;Flags: Precursor; | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
234
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:77522
Pflanz S, et al., IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4(+) T Cells. Immunity. 2002 Jun;16(6):779-90
J:86979 Lucas S, et al., IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15047-52 J:99680 The FANTOM Consortium and RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group), The Transcriptional Landscape of the Mammalian Genome. Science. 2005;309(5740):1559-1563 J:107281 Morishima N, et al., Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol. 2005 Aug 1;175(3):1686-93 J:112649 Stumhofer JS, et al., Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 2006 Sep;7(9):937-45 J:112662 Batten M, et al., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol. 2006 Sep;7(9):929-36 J:123476 Neufert C, et al., IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol. 2007 Jul;37(7):1809-16 J:126267 Villarino AV, et al., IL-27 limits IL-2 production during Th1 differentiation. J Immunol. 2006 Jan 1;176(1):237-47 J:129424 Owaki T, et al., IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol. 2006 Mar 1;176(5):2773-80 J:132223 Shimizu M, et al., Antiangiogenic and antitumor activities of IL-27. J Immunol. 2006 Jun 15;176(12):7317-24 J:139438 Yoshimura T, et al., Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol. 2006 Oct 15;177(8):5377-85 J:140602 Owaki T, et al., IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J Immunol. 2006 Dec 1;177(11):7579-87 J:148591 Molle C, et al., IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J Immunol. 2007 Jun 15;178(12):7607-15 J:151823 Fitzgerald DC, et al., Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol. 2007 Sep 1;179(5):3268-75 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/25/2025 MGI 6.24 |
![]() |
|